For more on Dr. Capurso and The Carlat Addiction Psychiatry Report at thecarlatreport.com/newsletters/5/…

Meet Chris Aiken, MD today at 8AM. Room 1A23 #APAAM24

Learn how to manage #lithium side effects, as well as new data on its medical and psychiatric benefits at American Psychiatric Association 2024 tomorrow 5/5 8am New York City.

I’ll be speaking with Bob Post and Janusz Rybakowski

Sleep improved as people with #alcohol use disorder drank less, even if they didn't stop altogether, in this secondary analysis of a large trial:
pubmed.ncbi.nlm.nih.gov/38606931

#soberliving #recovery #addiciton #sobriety

New in this issue: We delve into effective suicide prevention strategies, including Dr. Mann's insights on post-hospitalization care. Uncover the complexities of nonsuicidal self-injury with Dr. Dixon-Gordon #mentalhealth thecarlatreport.com/newsletters/2/…

Buprenorphine (Suboxone, Subutex) came up safer in pregnancy than methadone in new cohort study of 9514 pregnancies:
pubmed.ncbi.nlm.nih.gov/38252426

#opioidcrisis #opioidaddiction #TurnTheTide #psychiatry

Sharpen your diagnostic skills in the new Carlat Psychiatry Podcast, where clinicians who live with #mentalillness tell us what the symptoms are really like:
podcasts.apple.com/us/podcast/wou…

#psychiatry #depression #bipolar #anxiety #addiction #PTSD #psychosis #Schizophrenia

Art: Alan D.…

Update on #Ibogaine
> Robust effects in #PTSD and #opioid UD, but trials preliminary and only 1 randomized
> Acts on opioid/NMDA receptors, causing risky interactions w/other opioids
> Potential for fatal arrhythmia

From a new review by Owen Muir et al:
pubmed.ncbi.nlm.nih.gov/38518270

How to identify and manage alcohol withdrawal in psychiatric settings, using the CIWA-Ar scale for monitoring symptom progression. While benzodiazepines remain the primary treatment, alternative treatment strategies are discussed. #mentalhealth thecarlatreport.com/articles/4589-…

Explore practical applications of positive psychology in psychotherapy, gaining insights to foster resilience, happiness, and a sense of purpose in your client - by Daniel Carlat, MD #mentalhealth thecarlatreport.com/articles/4687-…

In this podcast, Dr. Brian Hurley provides expert insights into the current state of stimulant use disorder, its implications across different regions, and available treatment options. #addiction #mentalhealth thecarlatreport.com/blogs/2-the-ca…

There’s plenty you can do to reduce stress in your life, but some techniques take longer than others. When there isn’t time for a 30-minute workout or phone call with a loved one, you can de-stress in five minutes or less.

#HealthierTomorrows #StressRelief

Curved rooms boosted mood and #creativity more than rectangular rooms in new study (and calmed the heart rate):
pubmed.ncbi.nlm.nih.gov/38545212

More studies in Carlat #Psychiatry News
youtube.com/watch?v=BrHOEs…

#mentalhealth #architecture #psychology

Curcumin (Turmeric) has positive trials in #depression , but it failed to augment the SSRI sertraline (Zoloft) in this new RCT from Iran:
pubmed.ncbi.nlm.nih.gov/37071480

Some say Iran only publishes false-positive trials, but nothing is 100%. #psychiatry

Among #ADHD treatments, amphetamines had a slightly greater risk of causing psychosis than methylphenidate, and atomoxetine (Strattera) had no risk in this new large study, confirming an earlier report from NEJM:
pubmed.ncbi.nlm.nih.gov/38609318

#psychiatry #mentalhealth

Clinical tip: Opioid and benzodiazepine combinations are risky, but the risk goes down when one clinician monitors both scripts #mentalhealth thecarlatreport.com/articles/4109-…

How much does placebo account for #ketamine and #esketamine benefits? 72%, from new analysis:
pubmed.ncbi.nlm.nih.gov/38525254

Similar to placebo contribution for antidepressants (62-82%).

Meds make a real difference, but the power of the placebo is welcome news for the human spirit.

Age Moderates the Relation between Sleep Problems and Suicide Risk #geriatrics pubmed.ncbi.nlm.nih.gov/35209805/

Benzodiazepines are highly beneficial for managing anxiety and agitation in psychiatric inpatient settings, but in patients with substance use disorders, it can be risky. Here we review strategies to reduce the risk #psychtwitter thecarlatreport.com/articles/4590-…

1st lumateperone (Caplyta) RCT in major #depression :
> Aug #antidepressants , medium effect size (0.6)
> 6 wks, 485 pts, 1-2 failed med trials
> Fatigue, dry mouth, tremor main side effects

Data unpublished, summary here:
ir.intracellulartherapies.com/news-releases/…

2nd trial anticipated in summer.